RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Ihsan Salloum to Substance-Related Disorders

This is a "connection" page, showing publications Ihsan Salloum has written about Substance-Related Disorders.
Connection Strength

1.893
  1. Ware OD, Cano MT, Dalal Safa M, Garza N, Martinez S, Salloum I. Availability of substance use disorder treatment in Spanish: Associations with state-level proportions of Spanish speakers and treatment facility characteristics in the United States. Am J Addict. 2024 07; 33(4):400-408.
    View in: PubMed
    Score: 0.485
  2. Cisse A, Giles C, Salloum IM. Yoga in the Yard. Psychiatr Serv. 2017 09 01; 68(9):980.
    View in: PubMed
    Score: 0.311
  3. Salloum IM, Brown ES. Management of comorbid bipolar disorder and substance use disorders. Am J Drug Alcohol Abuse. 2017 07; 43(4):366-376.
    View in: PubMed
    Score: 0.301
  4. Douaihy AB, Stowell KR, Bui T, Daley D, Salloum I. HIV/AIDS and homelessness, Part 2: treatment issues. AIDS Read. 2005 Nov; 15(11):604-6, 611-3, 618.
    View in: PubMed
    Score: 0.137
  5. Douaihy AB, Stowell KR, Bui T, Daley D, Salloum I. HIV/AIDS and homelessness, Part 1: background and barriers to care. AIDS Read. 2005 Oct; 15(10):516-20, 527.
    View in: PubMed
    Score: 0.136
  6. Douaihy AB, Jou RJ, Gorske T, Salloum IM. Triple diagnosis: dual diagnosis and HIV disease, part 2. AIDS Read. 2003 Aug; 13(8):375-82.
    View in: PubMed
    Score: 0.117
  7. Douaihy AB, Jou RJ, Gorske T, Salloum IM. Triple diagnosis: dual diagnosis and HIV disease, Part 1. AIDS Read. 2003 Jul; 13(7):331-2, 339-41.
    View in: PubMed
    Score: 0.116
  8. Mar?n-Navarrete R, Medina-Mora ME, Horigian VE, Salloum IM, Villalobos-Gallegos L, Fern?ndez-Mondrag?n J. Co-Occurring Disorders: A Challenge for Mexican Community-Based Residential Care Facilities for Substance Use. J Dual Diagn. 2016 Jul-Dec; 12(3-4):261-270.
    View in: PubMed
    Score: 0.072
  9. Maremmani I, Pacini M, Lamanna F, Pani PP, Perugi G, Deltito J, Salloum IM, Akiskal H. Mood stabilizers in the treatment of substance use disorders. CNS Spectr. 2010 Feb; 15(2):95-109.
    View in: PubMed
    Score: 0.046
  10. Kilbourne AM, Salloum I, Dausey D, Cornelius JR, Conigliaro J, Xu X, Pincus HA. Quality of care for substance use disorders in patients with serious mental illness. J Subst Abuse Treat. 2006 Jan; 30(1):73-7.
    View in: PubMed
    Score: 0.035
  11. Cornelius JR, Clark DB, Bukstein OG, Birmaher B, Salloum IM, Brown SA. Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review. Addict Behav. 2005 Oct; 30(9):1824-33.
    View in: PubMed
    Score: 0.034
  12. Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, Bowden CL, Nierenberg AA, Pollack MH, Salloum IM, Simon NM, Thase ME, Sachs GS. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry. 2005 Jun; 66(6):730-5; quiz 808-9.
    View in: PubMed
    Score: 0.033
  13. Cornelius JR, Clark DB, Bukstein OG, Salloum IM. Treatment of co-occurring alcohol, drug, and psychiatric disorders. Recent Dev Alcohol. 2005; 17:349-65.
    View in: PubMed
    Score: 0.032
  14. Cornelius JR, Maisto SA, Pollock NK, Martin CS, Salloum IM, Lynch KG, Clark DB. Rapid relapse generally follows treatment for substance use disorders among adolescents. Addict Behav. 2003 Mar; 28(2):381-6.
    View in: PubMed
    Score: 0.028
  15. Kilbourne AM, Cornelius JR, Han X, Haas GL, Salloum I, Conigliaro J, Pincus HA. General-medical conditions in older patients with serious mental illness. Am J Geriatr Psychiatry. 2005 Mar; 13(3):250-4.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support